Sintofarm S.p.A.
Sintofarm S.p.A., a prominent player in the pharmaceutical industry, is headquartered in Italy and operates extensively across Europe and beyond. Founded in 1982, the company has established itself as a leader in the development and manufacturing of high-quality pharmaceutical products, particularly in the fields of oncology and pain management. With a commitment to innovation, Sintofarm S.p.A. offers a diverse range of core products, including advanced formulations and generics that cater to the evolving needs of healthcare professionals and patients. The company’s dedication to quality and efficacy has earned it a strong market position, recognised for its contributions to improving patient outcomes. Through strategic partnerships and a focus on research and development, Sintofarm continues to achieve significant milestones in the pharmaceutical landscape.
DitchCarbon Score
How does Sintofarm S.p.A.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Machinery and Equipment industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Sintofarm S.p.A.'s score of 18 is lower than 65% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Sintofarm S.p.A.'s reported carbon emissions
Sintofarm S.p.A., headquartered in Italy, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Furthermore, there are no documented reduction targets or climate pledges associated with the company. As a result, Sintofarm S.p.A. appears to lack formal commitments to carbon reduction initiatives or industry-standard climate frameworks such as the Science Based Targets initiative (SBTi). Without available data or commitments, it is challenging to assess their environmental impact or sustainability efforts within the pharmaceutical sector. In the context of the industry, many companies are increasingly adopting rigorous climate strategies and reporting frameworks to address climate change. However, Sintofarm S.p.A. has yet to establish a public stance or measurable goals in this regard.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Sintofarm S.p.A. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
